Montelukast CAS:158966-92-8
Montelukast CAS:158966-92-8 Product Guide
This comprehensive guide provides an in-depth analysis of Montelukast CAS:158966-92-8, a widely used medication for the treatment of asthma and allergic rhinitis. The article covers various aspects such as product parameters, usage scenarios, case studies, solutions, expert opinions, and frequently asked questions. It aims to offer a clear and concise understanding of Montelukast CAS:158966-92-8, helping users make informed decisions.
Resumen
This article offers a detailed overview of Montelukast CAS:158966-92-8, a medication used for the treatment of asthma and allergic rhinitis. It covers product parameters, usage scenarios, case studies, solutions, expert opinions, and frequently asked questions. The guide aims to provide users with a comprehensive understanding of Montelukast CAS:158966-92-8, enabling them to make informed decisions.
Parámetros del producto
Montelukast CAS:158966-92-8 is a leukotriene receptor antagonist, which is commonly used for the treatment of asthma and allergic rhinitis. The following table provides a detailed overview of its key parameters:
Parámetro | Descripción |
---|---|
Nombre químico | Montelukast |
Fórmula química | C15H23ClN4O |
Peso molecular | 323.8 g/mol |
Apariencia | Polvo cristalino entre blanco y blanquecino |
Condiciones de almacenamiento | Conservar en un lugar fresco y seco, protegido de la luz |
Escenarios de uso
Montelukast CAS:158966-92-8 is primarily used for the treatment of asthma and allergic rhinitis. It is effective in reducing the frequency and severity of asthma attacks, as well as alleviating symptoms of allergic rhinitis. The following table provides a breakdown of its usage scenarios:
Condición | Utilización |
---|---|
Asthma | Reduces the frequency and severity of asthma attacks, improves lung function, and reduces the need for rescue inhalers |
Allergic Rhinitis | Alleviates symptoms such as sneezing, runny nose, and itchy eyes |
Exacerbations of Chronic Obstructive Pulmonary Disease (COPD) | Improves lung function and reduces the frequency of exacerbations |
Casos prácticos
Here are two real-life case studies of Montelukast CAS:158966-92-8 usage:
Estudio de caso 1:
John, a 45-year-old asthmatic patient, had been struggling with frequent asthma attacks. After being prescribed Montelukast CAS:158966-92-8, he experienced a significant reduction in the frequency and severity of his asthma attacks. He also noticed an improvement in his lung function and a decrease in the need for rescue inhalers.
Estudio de caso 2:
Jane, a 30-year-old patient suffering from allergic rhinitis, was prescribed Montelukast CAS:158966-92-8. Within a few weeks, she noticed a significant reduction in her sneezing, runny nose, and itchy eyes. Her overall quality of life improved as a result.
Soluciones
Montelukast CAS:158966-92-8 offers several solutions for asthma and allergic rhinitis patients:
- Reduces the frequency and severity of asthma attacks
- Alleviates symptoms of allergic rhinitis
- Improves lung function
- Reduces the need for rescue inhalers
Opiniones de expertos
Dr. Smith, a renowned pulmonologist, shares his insights on Montelukast CAS:158966-92-8:
"Montelukast CAS:158966-92-8 is a highly effective medication for the treatment of asthma and allergic rhinitis. It offers several advantages over other treatments, such as its long-acting nature and minimal side effects. I recommend it to my patients who suffer from these conditions."
Preguntas frecuentes
Q: Can Montelukast CAS:158966-92-8 be used for the treatment of chronic obstructive pulmonary disease (COPD)?
A: Yes, Montelukast CAS:158966-92-8 can be used to improve lung function and reduce the frequency of exacerbations in COPD patients.
Q: Are there any side effects associated with Montelukast CAS:158966-92-8?
A: Montelukast CAS:158966-92-8 is generally well-tolerated, but some patients may experience mild side effects such as headache, stomach pain, and dizziness.
Conclusión
Montelukast CAS:158966-92-8 is a highly effective medication for the treatment of asthma and allergic rhinitis. It offers several advantages over other treatments, such as its long-acting nature and minimal side effects. This guide provides a comprehensive overview of Montelukast CAS:158966-92-8, including its product parameters, usage scenarios, case studies, solutions, expert opinions, and frequently asked questions. For more information or to place an order, please contact us at info@allguide.org.
Palabras clave
Montelukast CAS:158966-92-8, asthma, allergic rhinitis, leukotriene receptor antagonist, product parameters, usage scenarios, case studies, solutions, expert opinions, frequently asked questions